Cancer in emergencies: What can we do better to protect the most vulnerable?
Dr Bishal Gyawali presents his talk on cancer treatment’s financial toxicity (FT) in low-and-middle-income countries.
He first outlines the causes of financial toxicity before examining the consequences.
He continues by reviewing abstracts which look into assessing financial toxicity in LMICs specifically looking at a study assessing FT in India and then within Africa.
Dr Gyawali concludes by exploring the further research needed in order to get a wider understanding of FT in LMICs.
Cancer in emergencies: What can we do better to protect the most vulnerable?
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Management of prostate cancer in Africa: Looking to the future
Choosing Wisely in radiology Tanzania
The use of IORT at Universitätsmedizin Mannheim hospital
Why tumour markers are not recommended as screening tests
Lung cancer screening and treatment in the Philippines
Choosing Wisely to mitigate financial toxicity in cancer care in Africa